Variables | Accuracy | Kappa | Sensitivity | Specificity | P-value |
---|---|---|---|---|---|
Utero-vesical hypervascularity | 95.9 (88.6–99.1) | 0.92 | 90.3 (74.3–98) | 100 (91.8–100) | < 0.001 |
Bridging vessels | 94.6 (86.7–98.5) | 0.89 | 100 (88.8–100) | 90.7 (77.9–97.4) | < 0.001 |
Bladder interruption | 91.9 (83.2–97.0) | 0.84 | 86.0 (72.1–94.7) | 100 (88.8–100) | < 0.001 |
Subplacental hypervascularity | 90.5 (81.5–96.1) | 0.81 | 85.3 (68.9–95.1) | 95.0 (83.1–99.4) | < 0.001 |
New lacuna† | 91.5 (87.4–94.6) | 0.73 | 98.0 (95.0–99.5) | 68.4 (54.8–80.1) | < 0.001 |
Myometrial thinning | 78.4 (67.3–87.1) | 0.58 | 96.8 (83.3–99.9) | 65.1 (49.1–79.0) | < 0.001 |
Loss of clear zone | 71.6 (60.0–81.5) | 0.46 | 53.5 (37.7–68.8) | 96.8 (8.3–99.9) | < 0.001 |
Placental bulging | 66.2 (54.3–76.8) | 0.38 | 100 (88.8–100) | 41.9 (27.0–57.9) | < 0.001 |
Exophytic mass | 66.2 (54.3–76.8) | 0.38 | 100 (88.8–100) | 41.9 (27.0–57.9) | < 0.001 |